NO150000C - Analogifremgangsmaate for fremstilling av terapeutisk aktivt z-n,n-dimetyl-3-(4-bromfenyl)-3-(3-pyridyl)-allylamin-dihydroklorid-monohydrat - Google Patents
Analogifremgangsmaate for fremstilling av terapeutisk aktivt z-n,n-dimetyl-3-(4-bromfenyl)-3-(3-pyridyl)-allylamin-dihydroklorid-monohydratInfo
- Publication number
- NO150000C NO150000C NO771774A NO771774A NO150000C NO 150000 C NO150000 C NO 150000C NO 771774 A NO771774 A NO 771774A NO 771774 A NO771774 A NO 771774A NO 150000 C NO150000 C NO 150000C
- Authority
- NO
- Norway
- Prior art keywords
- bromphenyl
- allylamine
- pyridyl
- dimethyl
- preparation
- Prior art date
Links
- WFUAVXYXJOQWAZ-GVKRCPFFSA-N (z)-3-(4-bromophenyl)-n,n-dimethyl-3-pyridin-3-ylprop-2-en-1-amine;hydrate;dihydrochloride Chemical compound O.Cl.Cl.C=1C=CN=CC=1C(=C/CN(C)C)\C1=CC=C(Br)C=C1 WFUAVXYXJOQWAZ-GVKRCPFFSA-N 0.000 title 1
- 230000001225 therapeutic effect Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/36—Radicals substituted by singly-bound nitrogen atoms
- C07D213/38—Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Psychiatry (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pain & Pain Management (AREA)
- Pyridine Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE7605780A SE409706B (sv) | 1976-05-21 | 1976-05-21 | Forfarande for framstellning av n,n-dimetyl-3-(4-bromfenyl)-3-3(3-pyridyl)-allylamin dihydroklorid monohydrat |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO771774L NO771774L (no) | 1977-11-22 |
| NO150000B NO150000B (no) | 1984-04-24 |
| NO150000C true NO150000C (no) | 1984-08-01 |
Family
ID=20327944
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO771774A NO150000C (no) | 1976-05-21 | 1977-05-20 | Analogifremgangsmaate for fremstilling av terapeutisk aktivt z-n,n-dimetyl-3-(4-bromfenyl)-3-(3-pyridyl)-allylamin-dihydroklorid-monohydrat |
Country Status (19)
| Country | Link |
|---|---|
| JP (1) | JPS539311A (Sortimente) |
| AU (1) | AU512004B2 (Sortimente) |
| BE (1) | BE842368A (Sortimente) |
| CA (1) | CA1093560A (Sortimente) |
| CY (1) | CY1171A (Sortimente) |
| DE (1) | DE2721857A1 (Sortimente) |
| DK (1) | DK147048C (Sortimente) |
| FI (1) | FI67696C (Sortimente) |
| FR (1) | FR2351964A1 (Sortimente) |
| GB (1) | GB1561286A (Sortimente) |
| HK (1) | HK55782A (Sortimente) |
| IE (1) | IE45385B1 (Sortimente) |
| LU (1) | LU77244A1 (Sortimente) |
| MY (1) | MY8400046A (Sortimente) |
| NL (1) | NL7705529A (Sortimente) |
| NO (1) | NO150000C (Sortimente) |
| NZ (1) | NZ184146A (Sortimente) |
| SE (1) | SE409706B (Sortimente) |
| SG (1) | SG60682G (Sortimente) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE7909514L (sv) | 1979-11-16 | 1981-05-17 | Astra Laekemedel Ab | Nya halofenyl-pyridyl-allylaminderivat |
| US4639338A (en) * | 1984-08-06 | 1987-01-27 | Ciba-Geigy Corporation | Preparation of crystalline disodium 3-amino-1-hydroxypropane-1,1-diphosphonate pentahydrate |
| EP0919550A1 (en) | 1997-11-26 | 1999-06-02 | Ucb, S.A. | Pseudopolymorphic forms of 2-2-4-bis(4-fluorophenyl)methyl-1-piperazinyl-ethoxy acetic acid dihydrochloride |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE361663B (Sortimente) * | 1971-04-28 | 1973-11-12 | Haessle Ab |
-
1976
- 1976-05-21 SE SE7605780A patent/SE409706B/xx unknown
- 1976-05-31 BE BE167453A patent/BE842368A/xx not_active IP Right Cessation
-
1977
- 1977-05-03 LU LU77244A patent/LU77244A1/xx unknown
- 1977-05-13 AU AU25135/77A patent/AU512004B2/en not_active Expired
- 1977-05-14 DE DE19772721857 patent/DE2721857A1/de not_active Withdrawn
- 1977-05-17 IE IE1009/77A patent/IE45385B1/en unknown
- 1977-05-18 NL NL7705529A patent/NL7705529A/xx not_active Application Discontinuation
- 1977-05-19 NZ NZ184146A patent/NZ184146A/xx unknown
- 1977-05-19 FI FI771591A patent/FI67696C/fi not_active IP Right Cessation
- 1977-05-20 GB GB21340/77A patent/GB1561286A/en not_active Expired
- 1977-05-20 FR FR7715612A patent/FR2351964A1/fr active Granted
- 1977-05-20 CA CA278,877A patent/CA1093560A/en not_active Expired
- 1977-05-20 CY CY1171A patent/CY1171A/xx unknown
- 1977-05-20 DK DK221177A patent/DK147048C/da not_active IP Right Cessation
- 1977-05-20 NO NO771774A patent/NO150000C/no unknown
- 1977-05-21 JP JP5822377A patent/JPS539311A/ja active Pending
-
1982
- 1982-12-01 SG SG606/82A patent/SG60682G/en unknown
- 1982-12-30 HK HK557/82A patent/HK55782A/xx unknown
-
1984
- 1984-12-30 MY MY46/84A patent/MY8400046A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NL7705529A (nl) | 1977-11-23 |
| FI771591A7 (Sortimente) | 1977-11-22 |
| NO771774L (no) | 1977-11-22 |
| LU77244A1 (Sortimente) | 1977-08-22 |
| FI67696B (fi) | 1985-01-31 |
| GB1561286A (en) | 1980-02-20 |
| AU2513577A (en) | 1978-11-16 |
| SG60682G (en) | 1983-09-02 |
| FI67696C (fi) | 1985-05-10 |
| MY8400046A (en) | 1984-12-31 |
| DK147048C (da) | 1984-09-03 |
| IE45385B1 (en) | 1982-08-11 |
| DE2721857A1 (de) | 1977-12-01 |
| NO150000B (no) | 1984-04-24 |
| SE7605780L (sv) | 1977-11-22 |
| BE842368A (fr) | 1976-09-16 |
| HK55782A (en) | 1983-01-07 |
| SE409706B (sv) | 1979-09-03 |
| CA1093560A (en) | 1981-01-13 |
| DK221177A (da) | 1977-11-22 |
| IE45385L (en) | 1977-11-21 |
| FR2351964A1 (fr) | 1977-12-16 |
| NZ184146A (en) | 1979-07-11 |
| JPS539311A (en) | 1978-01-27 |
| CY1171A (en) | 1983-06-10 |
| FR2351964B1 (Sortimente) | 1981-03-20 |
| AU512004B2 (en) | 1980-09-18 |
| DK147048B (da) | 1984-03-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO147243C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive ftalanderivater | |
| NO152899C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive glycerolderivater. | |
| NO158099C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive karbostyrilderivater. | |
| NO151411C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 1-aryloksy-2-hydroksy-3-alkylenaminopropan-derivater | |
| NO149586C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive polypeptider | |
| NO151321C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive karbostyrilderivater | |
| NO151463C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive kinazolinderivater | |
| NO152972C (no) | Analogifremgangsmaate for fremstilling av 2-(1-fenylbenzimidazolyl)-acetohydroksamsyre med terapeutisk aktivitet. | |
| NO149102C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive trans-4-fenyl-1,2,3,4-tetrahydro-1-naftalenamin-derivater | |
| NO161117C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive cefalosporinderivater. | |
| NO156864C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive piperinderivater. | |
| NO148453C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive spirohydantoinderivater | |
| NO153569C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive merkaptoacetyl-prolin-derivater. | |
| NO156787C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive kinolonderivater. | |
| NO150884C (no) | Analogifremgangsmaate for fremstilling av nye, terapeutisk aktive imidazotiazolderivater | |
| NO146396C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrimidinderivater. | |
| NO159654C (no) | Analogifremgangsm te for fremstilling av terapeutisk aktive 2-guanidin-4-heteroaryltiazolderivater. | |
| NO145236C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive omega-aminocarboxylsyrederivater | |
| NO148416C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive tiazolidin-, morfolin- og tiazan-derivater | |
| NO150044C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive tetrazol-derivater | |
| NO147913C (no) | Analogifremgangsmaate for fremstilling av fysiologisk aktive pyrazolopyridiner | |
| NO145762C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive antracyklinglykosidiske forbindelser | |
| NO145198C (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktivt 1,2-benzisotia-zolinon-3 | |
| NO145951C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazolinderivater | |
| NO148488C (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktive acyl-benzimidazol-2-derivater |